After successful completion of planned inspections by the local health authorities, photonamic GmbH & Co. KG (photonamic), a pharmaceutical company focused on the development of 5-aminolevulinic acid (5-ALA) in various applications, was granted a Manufacturing License under GMP on March 27, 2024. With this new status, the company is now qualified to manufacture and release it´s pharmaceutical products for distribution. photonamic collaborates closely with contract manufacturers, but has also worked strategically on the incorporation of key supply functions into the organization.